Study of cenvacibart to prevent another stroke after a recent stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a new medicine called cenvacibart to see if it helps prevent another stroke in people who recently had a stroke or mini-stroke. If you join, you'll receive either the study drug or a placebo, along with standard antiplatelet treatment, to help reduce the risk of future strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke or a mini-stroke (TIA) within the last 30 days that was not caused by a heart rhythm problem
- You are planning to take antiplatelet medicine (like aspirin or clopidogrel) to prevent another stroke
- You do not need long-term blood thinners for a heart condition like atrial fibrillation or a mechanical heart valve
- Your stroke was not caused by surgery, a procedure, low blood pressure, or an artery tear
- You were mostly able to take care of yourself before this stroke (not severely disabled)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the drug cilostazol can help prevent another stroke or mini-stroke (TIA) in people who have already had one. It compares adding cilostazol to the standard blood-thinning medicines you and your doctor would normally use.
This trial tests whether the drug cilostazol can help prevent another stroke and slow down damage to the brain's small blood vessels. It may be a good option if you have recently had a small-vessel stroke and have white matter changes on your MRI.
This trial looks at MRI scans to compare two types of blood-thinning medicines (one that affects blood-clotting and one that affects platelets) after a recent stroke caused by severe narrowing in certain brain arteries. It may help doctors understand which treatment works best while checking how the blood vessels and brain tissue look on MRI.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This study tests whether the drug cilostazol, when added to your usual aspirin or clopidogrel, can help prevent another stroke. It is being done in Africa and may be a good option if you've recently had a stroke or mini-stroke and want to lower your risk of another one.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
Hear when a new Secondary Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.